Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Inventory (2022 - 2023)

Amylyx Pharmaceuticals (AMLX) has 2 years of Inventory data on record, last reported at $38.3 million in Q4 2023.

  • For Q4 2023, Inventory rose 292.29% year-over-year to $38.3 million; the TTM value through Dec 2023 reached $38.3 million, up 292.29%, while the annual FY2023 figure was $38.3 million, 292.29% up from the prior year.
  • Inventory reached $38.3 million in Q4 2023 per AMLX's latest filing, up from $32.4 million in the prior quarter.
  • Across five years, Inventory topped out at $38.3 million in Q4 2023 and bottomed at $563000.0 in Q3 2022.